Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP-2)
Showing 26 - 50 of >10,000
Pmm2-CDG, CDG1A Trial in Rochester, Philadelphia, Seattle (Placebo, Acetazolamide)
Active, not recruiting
- Pmm2-CDG
- CDG1A
- Placebo
- Acetazolamide
-
Rochester, Minnesota
- +2 more
Jan 12, 2023
Bioavailability Trial in Salaya (54Fe SO4, 57Fe Oat-1, 58Fe Oat-2)
Enrolling by invitation
- Bioavailability
- 54Fe SO4
- +5 more
-
Salaya, Nakhon Pathom, ThailandInstitute of Nutrition, Institute of Nutrition Mahidol Universit
Apr 9, 2023
COVID-19 Trial in Petach Tikva (no intervantion)
Active, not recruiting
- COVID-19
- no intervantion
-
Petach Tikva, IsraelSchneider Children's Medical Center
Sep 29, 2022
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Digestive Health, Gastrointestinal Health Trial in Guelph (Inulinase, Maltodextrin )
Not yet recruiting
- Digestive Health
- Gastrointestinal Health
- Inulinase
- Maltodextrin placebo
-
Guelph, Ontario, CanadaNutrasource site (Apex Trials)
Feb 24, 2023
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States
Not yet recruiting
- Cystic Fibrosis Lung
- +2 more
- RSP-1502
- Tobramycin inhalation solution
-
Tucson, Arizona
- +14 more
Aug 24, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2
- COVAC-2
- Saline Placebo
- (no location specified)
Aug 5, 2022
Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines Trial in Chongqing (drug, diagnostic test,
Completed
- Severe Acute Respiratory Syndrome-related Coronavirus
- +4 more
- Nifedipine 30 MG
- +10 more
-
Chongqing, Chongqing, ChinaResidential Address
Feb 1, 2023
Colorectal Cancer Metastatic Trial in Adelaide (CNA3103: 5 x 10^7 cells, CNA3103: 1.5 x 10^8 cells, CNA3103: 4.5 x 10^8 cells)
Not yet recruiting
- Colorectal Cancer Metastatic
- CNA3103: 5 x 10^7 cells
- +4 more
-
Adelaide, South Australia, AustraliaCarina Biotech Investigators
Feb 26, 2023
Associated With In-stent Restenosis After Percutaneous Coronary
Not yet recruiting
- In-stent Restenosis
- bone morphogenetic protein-2 (BMP-2)
- (no location specified)
Nov 20, 2023
COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))
Not yet recruiting
- COVID-19
- XBB.1.5 Vaccine (Booster)
- XBB.1.5 Vaccine (single dose)
-
Mobile, Alabama
- +29 more
Aug 4, 2023
Hiv Trial in Cape Town (Connect)
Enrolling by invitation
- Hiv
- Connect
-
Cape Town, Western Cape, South AfricaWestern Cape Department of Health and Wellbeing CDH or CHC
Nov 27, 2023
B-cell Malignancy, Low-grade, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma Trial in China (BGB-16673)
Recruiting
- B-cell Malignancy, Low-grade
- +4 more
-
Beijing, Beijing, China
- +8 more
Jul 20, 2022
SARS CoV 2 Infection Trial in Monastir (Spray with Hypochlorous Acid Group, Spray with Placebo Group)
Recruiting
- SARS CoV 2 Infection
- Spray with Hypochlorous Acid Group
- Spray with Placebo Group
-
Monastir, TunisiaSemir Nouira
May 16, 2023
Hyperlipemia Trial in Beijing (RBD7022, Placebo)
Recruiting
- Hyperlipemia
- RBD7022
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 12, 2023
SARS-CoV-2 RBD Antibody in My Duc Hospital Healthcare Workers
Completed
- Covid19
- Vaccine Reaction
- SARS-CoV-2 IgG II Quant
-
Ho Chi Minh City, Tan Binh, VietnamHOPE Research Center, My Duc Hospital
Aug 20, 2022
Sjögren Syndrome Trial in Worldwide (LOU064, Placebo)
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))
Not yet recruiting
- COVID-19
- NVX-CoV2373 (5μg)
- +6 more
-
Birmingham, Alabama
- +47 more
Jul 2, 2023
Fasting, Gastric Stasis, Perioperative Complication Trial in Varzea Grande (Gastric emptying after an oral supplement containing
Completed
- Fasting
- +3 more
- Gastric emptying after an oral supplement containing carbohydrates and whey protein
- Overnight Fast
-
Varzea Grande, Mato Grosso, BrazilCentro Universitário de Varzea Grande (UNIVAG)
Oct 7, 2022
Patients With Acute Myeloid Leukemia
Recruiting
- Acute Myeloid Leukemia, Adult
-
Freiburg, CA, GermanyMedical Center- University of Freiburg
Aug 4, 2023